Unknown

Dataset Information

0

Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.

ABSTRACT: The tumor necrosis factor (TNF) ligand and cognate TNF receptor superfamilies constitute an important regulatory axis that is pivotal for immune homeostasis and correct execution of immune responses. TNF ligands and receptors are involved in diverse biological processes ranging from the selective induction of cell death in potentially dangerous and superfluous cells to providing costimulatory signals that help mount an effective immune response. This diverse and important regulatory role in immunity has sparked great interest in the development of TNFL/TNFR-targeted cancer immunotherapeutics. In this review, I will discuss the biology of the most prominent proapoptotic and co-stimulatory TNF ligands and review their current status in cancer immunotherapy.

SUBMITTER: Bremer E 

PROVIDER: S-EPMC3693168 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.

Bremer Edwin E  

ISRN oncology 20130611

The tumor necrosis factor (TNF) ligand and cognate TNF receptor superfamilies constitute an important regulatory axis that is pivotal for immune homeostasis and correct execution of immune responses. TNF ligands and receptors are involved in diverse biological processes ranging from the selective induction of cell death in potentially dangerous and superfluous cells to providing costimulatory signals that help mount an effective immune response. This diverse and important regulatory role in immu  ...[more]

Similar Datasets

Unknown Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy.
| S-EPMC4030310 | biostudies-literature
Unknown Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members.
| S-EPMC6748612 | biostudies-literature
Unknown Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.
| S-EPMC2842000 | biostudies-literature
Unknown Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.
| S-EPMC6068811 | biostudies-literature
Unknown The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
| S-EPMC3611009 | biostudies-literature
Unknown Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAIL.
| S-EPMC4266180 | biostudies-literature
Unknown A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.
| S-EPMC7084274 | biostudies-literature
Unknown A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.
| S-EPMC2488301 | biostudies-literature
Unknown Tumor Necrosis Factor Superfamily: Ancestral Functions and Remodeling in Early Vertebrate Evolution.
| S-EPMC7674686 | biostudies-literature
Unknown Solution structure of the cysteine-rich domain in Fn14, a member of the tumor necrosis factor receptor superfamily.
| S-EPMC2760370 | biostudies-literature